Gujarat Terce Laboratories Limited (BOM:524314)
43.50
+0.11 (0.25%)
At close: Jan 21, 2026
BOM:524314 Revenue
In the fiscal year ending March 31, 2025, Gujarat Terce Laboratories had annual revenue of 501.95M INR with 4.63% growth. Gujarat Terce Laboratories had revenue of 123.24M in the quarter ending March 31, 2025, with 0.96% growth.
Revenue
501.95M
Revenue Growth
+4.63%
P/S Ratio
0.68
Revenue / Employee
2.06M
Employees
244
Market Cap
341.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 501.95M | 22.21M | 4.63% |
| Mar 31, 2024 | 479.75M | 11.92M | 2.55% |
| Mar 31, 2023 | 467.83M | 66.49M | 16.57% |
| Mar 31, 2022 | 401.34M | 149.56M | 59.40% |
| Mar 31, 2021 | 251.78M | -123.66M | -32.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| ANG Lifesciences India | 922.09M |
| Deccan Health Care | 847.12M |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Sandu Pharmaceuticals | 667.62M |
| Panjon | 463.51M |